Corporate news

  June 17, 2010, 1:47 pm

More Benadryl and Tylenol products recalled

By Mike Lillis

McNeil Consumer Healthcare, a division of Johnson & Johnson, has expanded its recall of Tylenol and Benadryl products this week, announcing that it will pull tainted pills "inadvertently omitted from the initial recall action." 

The company is pulling five lots of the drugs: four lots of 100-count Benadryl Ultratab tablets and one lot of 50-count Extra-Strength Tylenol Rapid Release Gels. Both are sold in the United States. 

The recalls — the third round since November — follow consumer complaints that the pills smelled moldy. Investigators determined that that the odor was caused by trace amounts of a chemical derived from other chemicals applied to the wooden pallets used to ship packaging materials. 

The recalls have been on Congress's radar, with the House oversight committee staging a hearing on the issue late last month. 


Archived under: Corporate news
comment Comments
E-mail Print share
  June 16, 2010, 4:03 pm

White House stops short of endorsing plan to get tougher on corporate fraudsters

By Mike Lillis

Independent federal auditors are urging reforms to grant the administration broader powers to punish business executives tied to healthcare fraud. So far, though, the White House hasn't signed on.

An administration official said Wednesday the White House has yet to take a position on the anti-fraud proposal, which would authorize the Health and Human Services Department (HHS) to boot corporate executives associated with fraud from all federal healthcare programs — even if they no longer work for the offending company. A loophole in the current law prevents HHS from using its exclusion authority if the executive steps down first. 

Appearing before the Ways and Means Health Subcommittee Tuesday, Lewis Morris, chief counsel for the HHS' Office of Inspector General (OIG), said closing the loophole would go a long way toward reining in Medicare fraud, which is estimated to cost taxpayers hundreds of billions of dollars each year.

The White House official said the administration agrees "that corporate officials need to be held responsible for their role in health care fraud, including being subject to program exclusion, prosecution and jail time where appropriate." But the official stopped short of backing the OIG's recommendation. 

Meanwhile, Florida Reps. Ron Klein (D) and Ileana Ros-Lehtinen (R) are pushing a legislative fix to the corporate fraud loophole — part of a larger bill designed to tackle Medicare fraud.  


Archived under: Corporate news
comment Comments
E-mail Print share
 
« Start< Prev1234567
 

More Videos »

On The Money Twitter - Click to follow
More From The Web
bloglogo

More Briefing Room »

More Congress Blog »

More Pundits Blog »

More Twitter Room »

More Hillicon Valley »

More E2-Wire (Energy) »

More Ballot Box »

More On The Money »

More Healthwatch »

More Floor Action »

More Transportation »

More DEFCON Hill »

More Global Affairs »

More In The Know »

More RegWatch »

Get latest news from The Hill direct to your inbox, RSS reader and mobile devices.